Pharmaceutical Commerce

Featured Content

Pharmaceutical Commerce - November 2025

Click here to read the articles and view the interactive digital edition

Building Resilient, Sustainable Pharma Supply Chains

Cencora executive Heather Zenk discusses how innovations in cold chain, data visibility, and sustainability strategies are transforming the drug delivery process.

Popping the Gross-to-Net Bubble, Part VI: The Future of Pharmaceutical Pricing

From patent cliffs and government price controls, to self-pay models and staff-model HMOs, a look at the forces that could deflate the bubble—and those factors likely to keep it afloat a while longer.

DSCSA Compliance: Milestones, More Deadlines—and the Road Ahead

Advice for pharma distributors and dispensers on what they should do now in order to solidify a secure supply chain.

Access Insights 2024: Playing the Chess Endgame

October 18, 2024

A panel dives into the current and future outlook of healthcare policies.

Pharma Pulse 10/18/24: Navigating Social Media Regulatory and Ethical Standards, Unmasking Health Care Fraud & more

October 18, 2024

The latest news for pharma industry insiders.

Access Insights 2024: Financial Headwinds and Tailwinds to Commercialization

October 17, 2024

Bill Roth, General Manager, Managing Partner, Blue Fin Group, discusses the key takeaways of this year's keynote speech.

Access Insights 2024: Practicing Proactivity by Mapping Out Future Chessboard Moves

October 17, 2024

Session dives into how healthcare policy implementation impacts stakeholders long-term.

Pharma Pulse 10/17/24: Disparities Exist in Use of PrEP, Can Passion and Profit Coexist in Pharma ESG Efforts? & more

October 17, 2024

The latest news for pharma industry insiders.

Access Insights 2024: Notable Breakout Sessions

October 16, 2024

William Sarraille, professor, University of Maryland Francis King Carey School of Law, discusses other standout sessions at this year’s Access Insights conference.

Access Insights 2024: Analyzing Drug Pricing and Reimbursement Data Amid a New Wave of CMS Price Requirements

October 16, 2024

The session dives into the obstacles surrounding data usability, mandate compliance, initial adoption, and limitations in this arena.

Pharma Pulse 10/16/24: Balancing Personalized Marketing and Maintaining Data Privacy, Is PBM Reform Nearing the Finish Line? & more

October 16, 2024

The latest news for pharma industry insiders.

Access Insights 2024: Playing the Chess Endgame: Healthcare Policies Targeting Drug Commercialization

October 15, 2024

William Sarraille, professor, University of Maryland Francis King Carey School of Law, discusses breakout session and the impact of healthcare policies on manufacturing and commercialization.

Access Insights 2024: Commercialization’s Financial Headwinds and Tailwinds

October 15, 2024

The conference’s opening keynote sets the scene for 2025 and the years to come.